Cited by 94Epilepsy research and treatmentCOVID-19 and Mental HealthCOVID-19 and healthcare impacts

Epilepsy in time of COVID-19: A survey-based study

Open access
Fonseca, Elena, Quintana, Manuel, Lallana, Sofía, Luis Restrepo, Juan, Abraira, Laura, Santamarina, Estevo, Seijo‐Raposo, Iván, Toledo, Manuel·2020·Acta Neurologica Scandinavica

Abstract

OBJECTIVES: Collateral damage may occur in epilepsy management during the coronavirus (COVID-19) pandemic. We aimed to establish the impact of this pandemic on epilepsy patients in terms of patient-reported seizure control and emerging symptoms. MATERIALS & METHODS: This is a cross-sectional study including consecutive patients assessed by telephone contact in an epilepsy clinic during the first month of confinement. Demographic and clinical characteristics were recorded, and a 19-item questionnaire was systematically completed. Data regarding the impact of confinement, economic effects of the pandemic, and subjective perception of telemedicine were recorded. Additional clinical data were obtained in patients with a COVID-19 diagnosis. RESULTS: Two hundred and fifty-five patients were recruited: mean age 48.2 ± 19.8 years, 121 (47.5%) women. An increase in seizure frequency was reported by 25 (9.8%) patients. Sixty-eight (26.7%) patients reported confinement-related anxiety, 22 (8.6%) depression, 31 (12.2%) both, and 72 (28.2%) insomnia. Seventy-three (28.6%) patients reported a reduction in economic income. Logistic regression analysis showed that tumor-related epilepsy etiology [OR = 7.36 (95% CI 2.17-24.96)], drug-resistant epilepsy [OR = 3.44 (95% CI 1.19-9.95)], insomnia [OR = 3.25 (95% CI 1.18-8.96)], fear of epilepsy [OR = 3.26 (95% CI 1.09-9.74)], and income reduction [OR = 3.65 (95% CI 1.21-10.95)] were associated with a higher risk of increased seizure frequency. Telemedicine was considered satisfactory by 214 (83.9%) patients. Five patients were diagnosed with COVID-19, with no changes in seizure frequency. CONCLUSIONS: The COVID-19 pandemic has effects in epilepsy patients. Patients with tumor-related, drug-resistant epilepsy, insomnia, and economic difficulties are at a higher risk of increased seizure frequency. Telemedicine represents a suitable tool in this setting.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ane.13335

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 24 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic re- view and meta-analysis. Int J Infect Dis. 2020;94:91-95.

Cited by

Sorted by citations

Authors
Fonseca, E., Quintana, M., Lallana, S., Luis Restrepo, J., Abraira, L., Santamarina, E., Seijo‐Raposo, I., & Toledo, M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Epilepsy Unit Neurology Department Vall d’Hebron University Hospital Barcelona Spain
Corresponding author
Santamarina, Estevo
Venue
Acta Neurologica Scandinavica
Publisher
Wiley
Published
2020-09-06
Volume
142
Issue
6
Pages
545-554
ISSN
  • 0001-6314 (ISSN-L)
  • 1600-0404
OpenAlex
W3049743666
Cited by
94
References
24
Citations by year
2026: 2 · 2025: 2 · 2024: 10 · 2023: 13 · 2022: 26 · 2021: 35 · 2020: 6
FWCI
14.59
Type
journal article
Language
en
Open access
Locations
  • Acta Neurologica Scandinavica (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
UCB Pharma
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Epilepsy research and treatment
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
Keywords
epilepsy, COVID-19 pandemic, seizure frequency, telemedicine, confinement, anxiety, depression, insomnia, economic hardship, drug-resistant epilepsy, tumor-related epilepsy, risk factors
MeSH terms
Symptom Flare Up, COVID-19, SARS-CoV-2, Adult, Aged, Cross-Sectional Studies, Epilepsy, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review